ACLE MEDICAL PARTNERSHIP
BRIDEWELL LANE, ACLE, NORWICH
CKD 4
The percentage of patients on the CKD register with hypertension who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 145 | 196 | 74.0% | |
| CKD 4 | 2008 | 214 | 271 | 79.0% | |
| CKD 5 | 2009 | 54 | 58 | 93.1% | |
| CKD 5 | 2010 | 3 | 3 | 100.0% | |
| CKD 5 | 2011 | 6 | 7 | 85.7% | |
| CKD 5 | 2012 | 8 | 8 | 100.0% | |
| CKD 5 | 2013 | 13 | 16 | 81.2% | |
| CKD003 | 2014 | 11 | 13 | 84.6% | |
| CKD003 | 2015 | 11 | 12 | 91.7% | |
| NM84 | 2016 | 8 | 11 | 72.7% | |
| NM84 | 2017 | 9 | 13 | 69.2% | |
| NM84 | 2018 | 8 | 14 | 57.1% | |
| NM84 | 2019 | 13 | 16 | 81.2% | |
| NM84 | 2020 | 15 | 20 | 75.0% | |
| NM84 | 2022 | 16 | 21 | 76.2% |
